A court in Munich has granted a preliminary injunction that will prevent MSD from distributing the subcutaneous version of its cancer immunotherapy Keytruda in the German market. The verdict is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback